A critical breakthrough in cancer study is arising with the use of nanobodies to reactivate dysfunctional p53. This crucial malignant suppressor protein is frequently lost in many kinds of tumors, causing uncontrolled https://minibookmarking.com/story22081653/mini-antibodies-reactivate-tumor-suppressor-p53-a-new-approach-for-cancer-management